Research Paper (136)

  • Disrupting the infectious disease ecosystem in the digital precision health era innovations and converging emerging technologies
    Disrupting the infectious disease ecosystem in the digital precision health era innovations and converging emerging technologies

    Abbo L.M.

    Get Access
  • Express Yourself: Quantitative Real-Time PCR Assays for Rapid Chromosomal Antimicrobial Resistance Detection in Pseudomonas aeruginosa
    Express Yourself: Quantitative Real-Time PCR Assays for Rapid Chromosomal Antimicrobial Resistance Detection in Pseudomonas aeruginosa

    Madden D.E.

    Get Access
  • Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus
    Novel Synergies and Isolate Specificities in the Drug Interaction Landscape of Mycobacterium abscessus

    Van N.

    Get Access
  • Concurrent local delivery of diflunisal limits bone destruction but fails to improve systemic vancomycin efficacy during staphylococcus aureus osteomyelitis
    Concurrent local delivery of diflunisal limits bone destruction but fails to improve systemic vancomycin efficacy during staphylococcus aureus osteomyelitis

    Spoonmore T.J.

    Get Access
  • Identification of novel trypanosoma cruzi proteasome inhibitors using a luminescence-based high-throughput screening assay
    Identification of novel trypanosoma cruzi proteasome inhibitors using a luminescence-based high-throughput screening assay

    Zmuda F.

    Get Access
  • Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy
    Piperacillin Population Pharmacokinetics and Dosing Regimen Optimization in Critically Ill Children Receiving Continuous Renal Replacement Therapy

    Thy M.

    Get Access
  • Single-center evaluation of the pharmacokinetics of WCK 5222 (cefepime-zidebactam combination) in subjects with renal impairment
    Single-center evaluation of the pharmacokinetics of WCK 5222 (cefepime-zidebactam combination) in subjects with renal impairment

    Preston R.A.

    Get Access
  • Model Based Estimation of Posaconazole Tablet and Suspension Bioavailability in Hospitalized Children Using Real-World Therapeutic Drug Monitoring Data in Patients Receiving Intravenous and Oral Dosing
    Model Based Estimation of Posaconazole Tablet and Suspension Bioavailability in Hospitalized Children Using Real-World Therapeutic Drug Monitoring Data in Patients Receiving Intravenous and Oral Dosing

    Kane Z.

    Get Access
  • In vitro and in vivo activity, tolerability, and mechanism of action of BX795 as an antiviral against herpes simplex virus 2 genital infection
    In vitro and in vivo activity, tolerability, and mechanism of action of BX795 as an antiviral against herpes simplex virus 2 genital infection

    Hopkins J.

    Get Access
  • Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi In Vitro and In Vivo
    Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi In Vitro and In Vivo

    Pandey R.P.

    Get Access
  • Pharmacokinetics and drug-drug interactions of lopinavir-ritonavir administered with first- and second-line antituberculosis drugs in HIV-infected children treated for multidrug-resistant tuberculosis
    Pharmacokinetics and drug-drug interactions of lopinavir-ritonavir administered with first- and second-line antituberculosis drugs in HIV-infected children treated for multidrug-resistant tuberculosis

    Van Der Laan L.E.

    Get Access
  • Tissue distribution and penetration of isavuconazole at the site of infection in experimental invasive aspergillosis in mice with underlying chronic granulomatous disease
    Tissue distribution and penetration of isavuconazole at the site of infection in experimental invasive aspergillosis in mice with underlying chronic granulomatous disease

    Lee A.

    Get Access
  • Accelerating drug development through repurposed FDAApproved drugs for COVID-19: Speed is important, not haste
    Accelerating drug development through repurposed FDAApproved drugs for COVID-19: Speed is important, not haste

    Gord J.T.

    Get Access
  • Intracellular pharmacodynamic modeling is predictive of the clinical activity of fluoroquinolones against tuberculosis
    Intracellular pharmacodynamic modeling is predictive of the clinical activity of fluoroquinolones against tuberculosis

    Donnellan S.

    Get Access
  • Trypanosoma cruzi Phosphomannomutase and Guanosine Diphosphate-Mannose Pyrophosphorylase Ligandability Assessment
    Trypanosoma cruzi Phosphomannomutase and Guanosine Diphosphate-Mannose Pyrophosphorylase Ligandability Assessment

    Zmuda F.

    Get Access
  • Frequent Transmission of Streptococcus pneumoniae Serotype 35B and 35D, Clonal Complex 558 Lineage, across Continents and the Formation of Multiple Clades in Japan
    Frequent Transmission of Streptococcus pneumoniae Serotype 35B and 35D, Clonal Complex 558 Lineage, across Continents and the Formation of Multiple Clades in Japan

    Shinohara K.

    Get Access
  • Trends and Risk Factors for Antimicrobial-Resistant Neisseria gonorrhoeae, Melbourne, Australia, 2007 to 2018
    Trends and Risk Factors for Antimicrobial-Resistant Neisseria gonorrhoeae, Melbourne, Australia, 2007 to 2018

    Williamson D.A.

    Get Access
  • Pharmacokinetics of benznidazole in experimental chronic chagas disease using the swiss mouse-berenice-78 trypanosoma cruzi strain model
    Pharmacokinetics of benznidazole in experimental chronic chagas disease using the swiss mouse-berenice-78 trypanosoma cruzi strain model

    de Jesus S.M.

    Get Access
  • Apramycin Overcomes the Inherent Lack of Antimicrobial Bactericidal Activity in Mycobacterium abscessus
    Apramycin Overcomes the Inherent Lack of Antimicrobial Bactericidal Activity in Mycobacterium abscessus

    Selchow P.

    Get Access
  • Identification of a Proteasome-Targeting Arylsulfonamide with Potential for the Treatment of Chagas' Disease
    Identification of a Proteasome-Targeting Arylsulfonamide with Potential for the Treatment of Chagas' Disease

    Lima M.L.

    Get Access
  • Real-World Performance of Susceptibility Testing for Ceftolozane/Tazobactam against Non-Carbapenemase- Producing Carbapenem-Resistant Pseudomonas aeruginosa
    Real-World Performance of Susceptibility Testing for Ceftolozane/Tazobactam against Non-Carbapenemase- Producing Carbapenem-Resistant Pseudomonas aeruginosa

    Rivas L.

    Get Access
  • Mechanistic modeling of Mycobacterium tuberculosis infection in murine models for drug and vaccine efficacy studies
    Mechanistic modeling of Mycobacterium tuberculosis infection in murine models for drug and vaccine efficacy studies

    Zhang N.

    Get Access
  • Benznidazole in cerebrospinal fluid: A case series of chagas disease meningoencephalitis in hiv-positive patients
    Benznidazole in cerebrospinal fluid: A case series of chagas disease meningoencephalitis in hiv-positive patients

    Fern?ndez M.L.

    Get Access
  • Population pharmacokinetics and dosing of ethionamide in children with tuberculosis
    Population pharmacokinetics and dosing of ethionamide in children with tuberculosis

    Nyberg H.B.

    Get Access
  • Imidazole derivatives as promising agents for the treatment of Chagas disease
    Imidazole derivatives as promising agents for the treatment of Chagas disease

    de Ara?jo J.S.

    Get Access
  • A pilot study of Chicago waterways as reservoirs of multidrug-resistant Enterobacteriaceae (MDR-ENT) in a high-risk region for community-acquired MDR-ENT infection in children
    A pilot study of Chicago waterways as reservoirs of multidrug-resistant Enterobacteriaceae (MDR-ENT) in a high-risk region for community-acquired MDR-ENT infection in children

    Logan L.K.

    Get Access
  • Inhibitory Activity of Antibacterial Mouthwashes and Antiseptic Substances against Neisseria gonorrhoeae
    Inhibitory Activity of Antibacterial Mouthwashes and Antiseptic Substances against Neisseria gonorrhoeae

    Williams E.

    Get Access
  • Combination therapy using benznidazole and aspirin during the acute phase of experimental chagas disease prevents cardiovascular dysfunction and decreases typical cardiac lesions in the chronic phase
    Combination therapy using benznidazole and aspirin during the acute phase of experimental chagas disease prevents cardiovascular dysfunction and decreases typical cardiac lesions in the chronic phase

    Pereira R.S.

    Get Access
  • Treatment of clostridium difficile infection with a small-molecule inhibitor of toxin UDP-glucose hydrolysis activity
    Treatment of clostridium difficile infection with a small-molecule inhibitor of toxin UDP-glucose hydrolysis activity

    Stroke I.L.

    Get Access
  • Efficacy of Olorofim (F901318) against Aspergillus fumigatus, A. Nidulans, and A. Tanneri in Murine Models of Profound Neutropenia and Chronic Granulomatous Disease
    Efficacy of Olorofim (F901318) against Aspergillus fumigatus, A. Nidulans, and A. Tanneri in Murine Models of Profound Neutropenia and Chronic Granulomatous Disease

    Seyedmousavi S.

    Get Access

Your Feedback